Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis (BSX-003)

This study has been terminated.
Information provided by:
Cerimon Pharmaceuticals Identifier:
First received: March 26, 2008
Last updated: August 17, 2010
Last verified: August 2010
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2008
  Primary Completion Date: November 2008 (Final data collection date for primary outcome measure)